ArticleInternational journal of hematology2022

Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma.

Rikio Suzuki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.